Thursday, December 02, 2021 6:00:44 PM
Gary,
If I want to have good night sleep and nice DREAM. I would read this post written by you. I definitely will have nice dream.
Honestly, according to my understanding of NWBO during past 4-5 years. The chance to have TLD, publication and BLA filing on the same day is very low.
Maybe I am wrong this time. But a 79 cents stock, suddenly jump to double digit, or even $20 stock overnight. I won't believe it. Unless TLD is SUPER GREAT! But if TLD is super great, why NWBO needs support from Journal publication? NWBO can just release TLD and file BLA at same day....
I am long on NWBO but I am in the camp that data is good but not great. I believe company knows TLD many months already. TLD is complicate and easily to be twisted. That is why NWBO need support from Journal publication.
My target price is $5 the day NWBO release the TLD. It might go up or down, touch $7-$8 or down to $3-4? it really depends....
If I want to have good night sleep and nice DREAM. I would read this post written by you. I definitely will have nice dream.
Honestly, according to my understanding of NWBO during past 4-5 years. The chance to have TLD, publication and BLA filing on the same day is very low.
Maybe I am wrong this time. But a 79 cents stock, suddenly jump to double digit, or even $20 stock overnight. I won't believe it. Unless TLD is SUPER GREAT! But if TLD is super great, why NWBO needs support from Journal publication? NWBO can just release TLD and file BLA at same day....
I am long on NWBO but I am in the camp that data is good but not great. I believe company knows TLD many months already. TLD is complicate and easily to be twisted. That is why NWBO need support from Journal publication.
My target price is $5 the day NWBO release the TLD. It might go up or down, touch $7-$8 or down to $3-4? it really depends....
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
